The prognosis and the impact of radiotherapy in clinically regional lymph node-positive prostate cancer: Which patients are candidates for local therapy with radiation?
暂无分享,去创建一个
Y. Shioyama | M. Shiota | A. Yokomizo | A. Takeuchi | E. Kashiwagi | J. Inokuchi | T. Yoshitake | R. Takahashi | K. Ishigami | M. Eto | H. Terashima | H. Iwai | Ken-ichiro Shiga | Kosuke Ieiri | Ken‐ichiro Shiga
[1] P. Kantoff,et al. Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019. , 2020, European urology.
[2] K. Kuroiwa,et al. Efficacy and safety of 4-weekly cabazitaxel for castration-resistant prostate cancer: a multi-institutional study , 2019, Cancer Chemotherapy and Pharmacology.
[3] M. Parmar,et al. Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis , 2019, European urology.
[4] Ronald C. Chen,et al. A Systematic Review of the Role of Definitive Local Treatment in Patients with Clinically Lymph Node-positive Prostate Cancer. , 2019, European urology oncology.
[5] A. Amini,et al. Node-positive Nonmetastatic Prostate Cancer: Time to Reconsider Prognostic Staging? , 2019, European urology.
[6] A. Zwinderman,et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. , 2019, European urology.
[7] K. Kuroiwa,et al. Efficacy and safety of cabazitaxel for castration-resistant prostate cancer in patients with > 10 cycles of docetaxel chemotherapy: a multi-institutional study , 2019, Medical Oncology.
[8] A. Partin,et al. Adjuvant radiation with androgen‐deprivation therapy for men with lymph node metastases after radical prostatectomy: identifying men who benefit , 2019, BJU international.
[9] E. Crawford,et al. A Clinician’s Guide to Next Generation Imaging in Patients With Advanced Prostate Cancer (RADAR III) , 2019, The Journal of urology.
[10] D. Elashoff,et al. Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT] , 2019, BMC Cancer.
[11] M. Parmar,et al. Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial , 2018, The Lancet.
[12] M. Menon,et al. Impact of Adjuvant Radiotherapy in Node-positive Prostate Cancer Patients: The Importance of Patient Selection. , 2018, European urology.
[13] Thomas Wiegel,et al. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. , 2018, European urology.
[14] M. Carducci,et al. Impact of ethnicity on the outcome of men with metastatic, hormone‐sensitive prostate cancer , 2017, Cancer.
[15] M. Parmar,et al. Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer: Data From Patients in the Control Arm of the STAMPEDE Trial. , 2016, JAMA oncology.
[16] A. Jemal,et al. Androgen deprivation with or without radiation therapy for clinically node-positive prostate cancer. , 2015, Journal of the National Cancer Institute.
[17] Cesare Cozzarini,et al. Impact of adjuvant radiotherapy on survival of patients with node-positive prostate cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] E. Crawford,et al. The impact of definitive local therapy for lymph node-positive prostate cancer: a population-based study. , 2014, International journal of radiation oncology, biology, physics.
[19] J. Tward,et al. Radiation therapy for clinically node-positive prostate adenocarcinoma is correlated with improved overall and prostate cancer-specific survival. , 2013, Practical radiation oncology.
[20] Susan Halabi,et al. Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] P. Malone,et al. Prostate , 1995 .
[22] H. Sakuma,et al. Multimodality Treatment for Patients with Node-Positive Prostate Cancer: the Role of Radiation Therapy. , 2016, Asian Pacific journal of cancer prevention : APJCP.